Philip Alex, M.D., Ph.D.

Chief Medical Officer

Dr. Philip Alex, M.D., Ph.D. obtained his Ph.D. in neuro-immunology and has over 20 years of experience in autoimmune, inflammatory, and translational research. His rigorous research and development leadership helped shape Haus’s evidence-based approach, bridging the gap between natural remedies and traditional medicine. Dr. Alex has been instrumental in the development of NanoCur, guiding its advanced formulation science, targeted anti-inflammatory design, and clinical strategy. He co-invented all of Haus’s curcumin delivery innovations – including patents US10968260B2 and WO2023023648A1 – which use natural nanotechnology breakthroughs to dramatically enhance curcumin absorption and potency. Beyond curcumin, Dr. Alex’s pioneering studies have unlocked key insights and novel therapies for inflammatory diseases like eczema, psoriasis, rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and viral infection, which includes numerous scientific publications and patents in the space. He combines deep scientific expertise with a patient-focused vision, translating cutting-edge science into natural solutions that improve lives.